Phase
Condition
Common Cold
Acute Rhinitis
Treatment
N/AClinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age older or equal to 18 and younger than 66 years;
Subjects diagnosed with common cold / flu syndrome defined by clinical evaluation andthe presence of two or more of the following symptoms: sneezing, rhinorrhea, nasalobstruction, headache, throat discomfort, sore throat, dysphonia, myalgia, cough andfever classified as moderate or intense in four intensity scale (04) items (0 =absent, 01 = light, 02 = moderate, 03 = severe);
Beginning of the symptoms of common cold / flu-like syndrome in a minimum period of 24hours and a maximum of 72 hours prior to V0;
Ability to understand and consent to participate in this clinical research, expressedby signing the Informed Consent Form (ICF);
Exclusion
Exclusion Criteria:
Any laboratorial finding (clinical evaluation / physical evaluation / vital signs /ECG changes) that the Investigator consider a risk to subject of the study;
Hypersensitivity to the drug components used during the study;
Women in pregnancy or nursing period;
Women in reproductive age who do not agree to use contraception acceptable [oralcontraceptives, injectable contraceptives, intrauterine device (IUD), hormonalimplants, barrier methods, hormonal patch and tubal ligation]; other than surgicallysterile (bilateral oophorectomy or hysterectomy), postmenopausal for at least one (01)years or sexual abstinence;
Subjects that has participated in clinical trial protocols in the last twelve (12)months (National Board of Health- Resolution 251 of 07 August 1997, Part III, sub-itemJ), unless the investigator considers that there may be a direct benefit to it;
Alcohol abuse that, according to the investigator, may interfere with thepharmacological adherence to the clinical protocol;
Any medical conditions which may interfere with efficacy and / or safety of thetreatment with the investigational product, such as but not limited to disordersdescribed below:
Untreated or uncontrolled Hyperthyroidism
Uncontrolled epilepsy
diagnosis of glaucoma
Moderate or severe persistent asthma (untreated or uncontrolled)
NSAID-induced asthma diagnosed
Systemic hypertension (SH) stage III uncontrolled
Moderate and severe congestive heart failure
Acute myocardial infarction
unstable angina
Uncontrolled cardiac arrhythmia
Liver failure with clinical consequences
Renal failure with clinical consequences
Diagnosed HIV positive
uncontrolled Diabetes type 1 or type 2
Study Design
Study Description
Connect with a study center
Allergisa Pesquisa Dermato Cosmética Ltda.
Campinas, São Paulo
BrazilSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.